XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.20.2

Earnings per Common Share | 6 Months Ended
--- | ---
Jun. 30, 2020
Earnings Per Share [Abstract] |
Earnings per Common Share | Earnings per Common Share The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 48.2 |  |  | $ | 111.0 |  |  | $ | 157.0 |  |  | $ | 236.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (14.8 | ) |  | (19.7 | ) |  | (36.5 | ) |  | (42.6 | )
Less: Income allocated to participating securities | — |  |  | (0.3 | ) |  | (0.4 | ) |  | (0.7 | )
Income from continuing operations attributable to Encompass Health common shareholders | 33.4 |  |  | 91.0 |  |  | 120.1 |  |  | 193.4 |
Income (loss) from discontinued operations, net of tax, attributable to Encompass Health common shareholders | 0.1 |  |  | (0.1 | ) |  | — |  |  | (0.6 | )
Net income attributable to Encompass Health common shareholders | $ | 33.5 |  |  | $ | 90.9 |  |  | $ | 120.1 |  |  | $ | 192.8 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 98.7 |  |  | 98.0 |  |  | 98.5 |  |  | 98.2 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.34 |  |  | $ | 0.93 |  |  | $ | 1.22 |  |  | $ | 1.97 |
Discontinued operations | — |  |  | — |  |  | — |  |  | (0.01 | )
Net income | $ | 0.34 |  |  | $ | 0.93 |  |  | $ | 1.22 |  |  | $ | 1.96 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 48.2 |  |  | $ | 111.0 |  |  | $ | 157.0 |  |  | $ | 236.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (14.8 | ) |  | (19.7 | ) |  | (36.5 | ) |  | (42.6 | )
Income from continuing operations attributable to Encompass Health common shareholders | 33.4 |  |  | 91.3 |  |  | 120.5 |  |  | 194.1 |
Income (loss) from discontinued operations, net of tax, attributable to Encompass Health common shareholders | 0.1 |  |  | (0.1 | ) |  | — |  |  | (0.6 | )
Net income attributable to Encompass Health common shareholders | $ | 33.5 |  |  | $ | 91.2 |  |  | $ | 120.5 |  |  | $ | 193.5 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 99.9 |  |  | 99.3 |  |  | 99.6 |  |  | 99.5 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.34 |  |  | $ | 0.92 |  |  | $ | 1.21 |  |  | $ | 1.95 |
Discontinued operations | — |  |  | — |  |  | — |  |  | (0.01 | )
Net income | $ | 0.34 |  |  | $ | 0.92 |  |  | $ | 1.21 |  |  | $ | 1.94 |
The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Basic weighted average common shares outstanding | 98.7 |  |  | 98.0 |  |  | 98.5 |  |  | 98.2 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.2 |  |  | 1.3 |  |  | 1.1 |  |  | 1.3 |
Diluted weighted average common shares outstanding | 99.9 |  |  | 99.3 |  |  | 99.6 |  |  | 99.5 |
See Note 17, Earnings per Common Share, to the consolidated financial statements accompanying the 2019 Form 10‑K for additional information related to our common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration